Influenza Antiviral Drugs and Patent Law Issues

Description:

This report identifies and analyzes the patent law aspects of the current avian
influenza drug situation. First, the report explains the role that patent rights have
played in affecting the availability of Tamiflu. Second, the report examines options
for increasing the drug’s production, including the possibility of governments
abrogating Roche’s patent rights by issuing compulsory licenses to other drug
companies to manufacture generic versions of Tamiflu without Roche’s consent.

Creator(s): Yeh, Brian T.
Location(s): United States
Creation Date: November 18, 2005
Partner(s):
UNT Libraries Government Documents Department
Collection(s):
Congressional Research Service Reports
Usage:
Total Uses: 47
Past 30 days: 0
Yesterday: 0
Creator (Author):
Yeh, Brian T.

Legislative Attorney

Publisher Info:
Place of Publication: Washington D.C.
Date(s):
  • Creation: November 18, 2005
Coverage:
Place
United States
Description:

This report identifies and analyzes the patent law aspects of the current avian
influenza drug situation. First, the report explains the role that patent rights have
played in affecting the availability of Tamiflu. Second, the report examines options
for increasing the drug’s production, including the possibility of governments
abrogating Roche’s patent rights by issuing compulsory licenses to other drug
companies to manufacture generic versions of Tamiflu without Roche’s consent.

Physical Description:

15 Pages.

Language(s):
Subject(s):
Partner:
UNT Libraries Government Documents Department
Collection:
Congressional Research Service Reports
Identifier:
Resource Type: Report
Format: Text